propionylcarnitine has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, A; Bertelli, AA; Galmozzi, G; Giovannini, L | 1 |
| Bartels, GL; Holwerda, KJ; Kruijssen, DA; Remme, WJ | 1 |
| Izzo, A; Koverech, A; Liguori, M; Messano, M; Palermo, G; Riccioni, C; Sarcinella, R; Virmani, A | 1 |
| Alvarez de Sotomayor, M; Herrera, MD; Justo, ML; Mingorance, C; RodrÃguez-RodrÃguez, R | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
2 review(s) available for propionylcarnitine and cardiovascular agents
| Article | Year |
|---|---|
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.
Topics: Acetylcarnitine; Animals; Cardiovascular Agents; Cardiovascular Diseases; Carnitine; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin Resistance; Treatment Outcome | 2011 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
2 trial(s) available for propionylcarnitine and cardiovascular agents
| Article | Year |
|---|---|
Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiotonic Agents; Cardiovascular Agents; Carnitine; Cross-Over Studies; Diltiazem; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Treatment Outcome | 1996 |
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Topics: Aged; Arterial Occlusive Diseases; Cardiovascular Agents; Carnitine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Female; Humans; Infusions, Intravenous; Intermittent Claudication; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Quality of Life; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Walking | 2008 |
1 other study(ies) available for propionylcarnitine and cardiovascular agents
| Article | Year |
|---|---|
Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
Topics: Animals; Cardiovascular Agents; Carnitine; Carrageenan; Endothelins; Male; Rats; Rats, Wistar; Regional Blood Flow; Serotonin; Tail; Thrombosis; Vascular Diseases | 1993 |